Home > Newsletters > International Pharmaceutical Regulatory Monitor > SFDA Proposes ‘Blacklist’ to Shame Drugmakers into Higher Standards
International Pharmaceutical Regulatory Monitor
June 2012 | Vol. 40 No. 6
SFDA Proposes ‘Blacklist’ to Shame Drugmakers into Higher Standards
Stung by the chromium-contaminated drug capsule scandal, China’s State Food and Drug Administration (SFDA) is proposing to “blacklist” executives who oversee pharma companies found to produce substandard or counterfeit drugs.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.